BALTIMORE, Md.--DNA Bactofection, a novel technology for introducing genes into cells using live, attenuated invasive bacterial vectors, has been licensed to Microscience Ltd. by the University System ...

LONDON - Microscience Ltd. is being acquired by U.S. company Emergent BioSolutions Inc. in an all-paper deal that values the vaccine specialist at £40 million (US$73.1 million), roughly £5 million ...

A British company developing a vaccine for "Delhi belly" hopes to raise £40m next month when it becomes the latest British biotechnology firm to brave flotation. Microscience, with several drugs in ...

Microscience, the biotechnology company developing a vaccine against the most common cause of traveller's diarrhoea or "Delhi belly", is planning to float on Aim for about £100m. The company has ...

The event is organized by the UK-based Royal Microscopical Society (RMS), and will open with a plenary lecture from Sir David King, who was science and technology advisor to the UK government from ...

The University of Maryland Biotechnology Institute announced Friday that it has licensed to Microscience Ltd. a technology delivers DNA into cells. The licensing agreement allows United Kingdom-based ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

FLOTATION of a Wokingham-based biotechnology company will net £10m for its management and founders, including five London doctors. Microscience intends to float on Aim next month, raising £40m of new ...

Microscience, the vaccines developer, pulled its £140m stock market flotation yesterday, blaming poor market demand for its shares. It announced plans to float on the Alternative Investment Market in ...

Microscience, London, raised $36.4 million in third-round funding. The investment was led by Advent Venture Partners, J.P. Morgan Partners, Apax Partners Funds, and Merlin Biosciences. The company ...